BNP Paribas Asset Management
IDYA icon

BNP Paribas Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

BNP Paribas Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.3M Buy
1,269,889
+168,744
+15% +$5.17M 0.05% 352
2026
Q1 		$36.7M Buy
1,101,145
+403,220
+58% +$13.5M 0.04% 398
2025
Q4 		$24.1M Buy
697,925
+289,473
+71% +$9.23M 0.03% 493
2025
Q3 		$11.1M Buy
408,452
+407,751
+58,167% +$9.86M 0.03% 422
2025
Q2 		$15K Buy
+701
New +$13.4K ﹤0.01% 1619

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BNP Paribas Asset Management's IDYA Position: Q2 2026 in Review

BNP Paribas Asset Management increased its IDEAYA Biosciences (IDYA) stake by 15% in Q2 2026, buying an estimated $5.17M and bringing the position to 1,269,889 shares worth $47.3M. The position accounts for 0.05% of the portfolio, ranked #352.

BNP Paribas Asset Management first reported a position in IDYA in Q2 2025 and has held it in 5 quarters since. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • BNP Paribas Asset Management held 1,269,889 shares of IDEAYA Biosciences worth $47.3M as of Q2 2026.
  • BNP Paribas Asset Management bought 168,744 IDEAYA Biosciences shares in Q2 2026, an estimated $5.17M.
  • IDEAYA Biosciences made up 0.05% of BNP Paribas Asset Management's portfolio in Q2 2026, its #352 holding.
  • BNP Paribas Asset Management first reported a position in IDEAYA Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.